Literature DB >> 2574313

Familial patterns of narcolepsy.

C Guilleminault1, E Mignot, F C Grumet.   

Abstract

Familial patterns of narcolepsy were investigated in a clinic population of 334 unrelated narcoleptic patients. 40% of probands had at least 1 family member with an isolated daytime sleepiness complaint and 6% had a positive family history of narcolepsy. Multicase families were rare; only two families were found with 3 or more affected relatives. Family members often shared the same HLA-DR2 haplotype as the proband but did not have narcolepsy. However, the risk of disease for first-degree relatives was six to eighteen times greater than that for unrelated individuals. Although most patients were HLA-DR2+, 2 new HLA-DR2- individuals were found. The data predict that as many as 9% of unrelated North-American white patients with narcolepsy will be DR2-. Analysis of these and other data indicates that although strongly associated with disease, the HLA-DR2 haplotype is neither sufficient nor necessary for the development of narcolepsy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574313     DOI: 10.1016/s0140-6736(89)91977-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

Review 1.  Narcolepsy in children: a practical guide to its diagnosis, treatment and follow-up.

Authors:  C Guilleminault; R Pelayo
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

Review 2.  Narcolepsy: immunological aspects.

Authors:  Sebastiaan Overeem; John Logan Black; Gert Jan Lammers
Journal:  Sleep Med Rev       Date:  2008-03-04       Impact factor: 11.609

Review 3.  Genetics of narcolepsy and other sleep disorders.

Authors:  E Mignot
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

4.  Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment.

Authors:  E Mignot; C Wang; C Rattazzi; C Gaiser; M Lovett; C Guilleminault; W C Dement; F C Grumet
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  1992 American Society of Human Genetics presidential address: back to the future.

Authors:  W E Nance
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

Review 6.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

7.  IgH (mu-switch and gamma-1) region restriction fragment length polymorphism in human narcolepsy.

Authors:  S M Singh; C F George; R N Ott; C Rattazzi; C Guilleminault; W C Dement; E Mignot
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

Review 8.  From wakefulness to excessive sleepiness: what we know and still need to know.

Authors:  Maurice Moyses Ohayon
Journal:  Sleep Med Rev       Date:  2008-04       Impact factor: 11.609

9.  Treatment of narcolepsy with methamphetamine.

Authors:  M M Mitler; R Hajdukovic; M K Erman
Journal:  Sleep       Date:  1993-06       Impact factor: 5.849

10.  The familial risk and HLA susceptibility among narcolepsy patients in Hong Kong Chinese.

Authors:  Lei Chen; S Y Y Fong; Ching W Lam; Nelson L S Tang; Margaret H L Ng; Albert M Li; C K W Ho; Suk-Hang Cheng; Kin-Mang Lau; Yun Kwok Wing
Journal:  Sleep       Date:  2007-07       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.